Measuring the contribution of tumor biobanks to research in oncology: Surrogate indicators and bibliographic output

Biopreservation and Biobanking

Volumn 11, Issue 4, 2013, Pages 235-244

  Hofman, Véronique ^a   Ilie, Marius ^a   Long, Elodie ^a   Washetine, Kevin ^a   Chabannon, Christian ^b,c   Figarella Branger, Dominique ^c,d   Clément, Bruno ^e,f   Mabile, Laurence ^g   Cambon Thomsen, Anne ^g   Boucher, Pascal ^h   Dagher, Georges ^e   Hewitt, Robert ⁱ   Parodi, Barbara ^j   Hofman, Paul ^a,c,e  

^a PASTEUR HOSPITAL   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c Canceropole PACA   (France)

^d TIMONE HOSPITAL   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g UNIVERSITÉ PAUL SABATIER   (France)

^h INSTITUT NATIONAL DU CANCER   (France)

ⁱ Middle Eastern and African Society for Biopreservation and Biobanking   (France)

^j UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ACCREDITATION; ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER SURVIVAL; CELL DEATH; CELL STRUCTURE; HEALTH CARE POLICY; HOSPITAL INTEGRATED TUMOR BIOBANK; INFLAMMATORY CELL; MOLECULAR DIAGNOSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PRODUCTIVITY; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PUBLICATION; QUALITY CONTROL; SCORING SYSTEM; TIME; TISSUE MICROARRAY; TOTAL QUALITY MANAGEMENT; TRANSLATIONAL RESEARCH; ECONOMICS; HEALTH CARE FACILITY; HOSPITAL; HUMAN; JOURNAL IMPACT FACTOR; ORGANIZATION AND MANAGEMENT; STANDARDS;

HOSPITALS; HUMANS; JOURNAL IMPACT FACTOR; QUALITY CONTROL; TISSUE BANKS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84882939661     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0015     Document Type: Article

References (24)

1. Cambon-Thomsen A. Assessing the impact of biobanks. Nat Genet 2003;34:25-26
2. Hewitt R, Hainaut P. Biobanking in a fast moving world: An international perspective. J Natl Cancer Inst Monogr 2011; 2011:50-51
3. Womack C, Gray NM. Banking human tissue for research: Vision to reality. Cell Tissue Bank 2009;10:267-270
4. Hewitt RE. Biobanking: The foundation of personalized medicine. Curr Opin Oncol 2011;23:112-119
5. Bevilacqua G, Bosman F, Dassesse T, et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch 2010;456:449-454
6. Moore HM, Kelly A, Jewell SD, et al. Biospecimen reporting for improved study qualiy. Biopreserv Biobanking 2011;9:57-70
7. Ma Y, Dai H, Kong X. Impact of warm ischemia on gene expression analysis in surgically removed biosamples. Anal Biochem 2012;423:229-235
8. Betsou F, Gunter E, Clements J, et al. Identification of evidencebased biospecimen quality-control tools: A report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. J Mol Diagn 2013; 15:3-16
9. Riegman PH, van Veen EB. Biobanking residual tissues. Hum Genet 2011;130:357-368
10. Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 2006;7:266-269 (Pubitemid 43286456)
11. Hofmann B. Broadening consent-And diluting ethics? J Med Ethics 2009;35:125-129
12. Steinsbekk KS, Ka° re Myskja B, Solberg B. Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? Eur J Hum Genet 2013 Jan 9. doi: 10.1038/ejhg
13. Malin B, Loukides G, Benitez K, Clayton EW. Identifiability in biobanks: Models, measures, and mitigation strategies. Hum Genet 2011;130:383-392
14. http://www.e-cancer.fr/recherche
15. http://www.chu-montpellier.fr/publications/rubrique.jsp
16. Etude des coû ts de fonctionnement et recommandations pour la mise à disposition des ressources biologiques à des fins de recherche. http://www.e-cancer.fr/recherche/les-ressourcesbiologiques. Last accessed in 2013
17. Kiehntopf M, Krawczak M. Biobanking and international interoperability: Samples. Hum Genet 2011;130:369-376
18. Cambon-Thomsen A, Thorisson GA, Mabile L; BRIF Workshop Group. The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet 2011;43: 503-504
19. Wescott L, Laskofski M. Grant writing tips for translational research. Methods Mol Biol 2012;823:379- = 389
20. Lochmü ller H, Schneiderat P. Biobanking in rare disorders. Adv Exp Med Biol 2010;686:105-113
21. Yuille M, van Ommen GJ, Bréchot C, et al. Biobanking for Europe. Brief Bioinform 2008;9:14-24
22. Morente MM, Fernández PL, de Alava E. Biobanking: Old activity or young discipline? Semin Diagn Pathol 2008;25:317-322
23. http://www.estbb.fr/master-pro
24. http://www.gen2phen.org/groups/brif-bio-resource-impact-factor